triple glp 1 agonist LY3437943, a novel glucagon, GIP, and GLP-1 receptor for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

Abbreviations HT: Hashimotos thyroiditis TPO-Ab: Thyroid peroxidase antibody TG-Ab: Thyroglobulin antibody LT-4: L-thyroxine TSH: Thyroid-stimulating hormone IL: Interleukin TNF: Tumor necrosis factor IFN: Interferon SF-36: Short Form 36 Health Survey References McLeod, D

& Wandinger-Ness, A

Uncommon side effects of these medications can include pancreatitis, gastroparesis, bowel obstruction, gallstone attacks and bile duct blockages

Individual results may vary, and your healthcare provider will adjust your dosage based on how your body responds to each dose

4,5,236,237,238 A 2018 expert panel on cholesterol management, representing numerous cardiology and physician societies, including the American College of Cardiology and American Heart Association, referred to ApoB as a stronger indicator of atherogenicity than LDL-cholesterol alone, and recommended measurement of ApoB for cardiovascular risk assessment, especially in those with elevated triglycerides